Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Interactive app allows users to explore data underlying estimates of global AMR burden

Map of the world showing AMR prevalence and mortality

Providing a closer snapshot of health loss linked to antimicrobial resistance (AMR), the Global Research on Antimicrobial Resistance (GRAM) Project, has released a visualization tool (page opens on the GRAM website) that measures worldwide AMR burden and related metrics—including pathogen and infectious syndrome deaths—by country, age, bacteria and antibiotic.

The tool, released by the GRAM partnership between the Institute for Health Metrics and Evaluation (IHME) and the University of Oxford, follows the team’s January report which estimated that bacterial AMR caused more than 1.2 million deaths in 2019. Read the study, ‘Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis’, in the Lancet.

Supported by the UK Fleming Fund, the Wellcome Trust, and the Bill and Melinda Gates Foundation, the GRAM findings described AMR as a leading cause of death, and an urgent problem in both low- and high-resource settings. Data collected by GRAM, and analyzed using methodologies from IHME’s ongoing Global Burden of Disease study, represent one of the most comprehensive AMR datasets available, with 471 million separate records.

The tool allows users to generate maps, graphs and other data collected by GRAM, including those showing AMR prevalence and mortality in 204 countries, and for 88 pathogen-and-antibiotic combinations.

In addition to resistance, the tool also allows viewers to explore estimates that researchers used to calculate the burden of AMR, including data on infectious syndromes and bacterial infections.

Users may review deaths and disability adjusted life years (DALYs) for seven infectious syndromes—including bloodstream and lower respiratory infections—by age and sex. The tool also lists deaths and DALYs by pathogen, including 33 bacteria, and several viruses and fungi.

GRAM researchers have cited lack of available data as a key limitation of their research. Indeed, limited data is available for many parts of the world, particularly low- and middle-income settings, where the estimated burden of AMR is greatest.   

Similar stories

Study finds almost two-thirds of patients are systematically excluded from drug trials

A new WWARN study has found that nearly two-thirds of the malaria-positive patients who present to health facilities are systematically excluded from “classical” anti-malarial treatment efficacy trials.

Watch our webinar - Radical cure of vivax malaria: can we do better?

The three presentations and expert discussion by Dr Rob Commons, Dr Alison Roth and Dr James Watson, chaired by Professor Sir Nicholas White (Mahidol Oxford Research Unit) and Dr Chau Nguyen Hoang (Oxford University Clinical Research Unit), are now available.

Shobhana Nagraj, Women in Science

Clinical Researcher Shobhana Nagraj, from the Health Systems Collaboratives in Oxford, tells us about the female role models who inspired her to follow her dreams

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Expert Comment: Biotechnology allows us to make unprecedented interventions for conservation

In the wake of high-profile reports on the devastating toll human activity has had on global biodiversity, nations are expected to adopt the Convention on Biodiversity post-2020 framework that outlines measures to ensure humans live in harmony with nature.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.